JACQUELINE CURISTON: Open Payments
NPI 1336779958 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 25 payments from 13 companies in 2025. Trend: 2023 $1,816 · 2024 $1,225 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $143 |
| Janssen Biotech, Inc. | 4 | $93 |
| Alexion Pharmaceuticals, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $71 |
| ARGENX US, INC. | 3 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $66 |
| ABBVIE INC. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| HOSPIRA, INC. | 1 | $28 |
| Grifols USA, LLC | 1 | $25 |
Products named: BENLYSTA, TREMFYA, ULTOMIRIS, VYEPTI, VYVGART HYTRULO, ONPATTRO, HYQVIA, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MI — which companies pay providers there.
